Digital Innovation: Cancer-Specific AI Use Cases at Clinical Pathways Congress
Douglas Flora shared a post by Clinical Pathways Congress + Cancer Care Business Exchange on LinkedIn, adding:
“Excited for this panel with some of the most innovative thinkers in Oncology today. Who else will be attending the Clinical Pathways Congress in Boston this year? I’ll be sharing some of the great things happening at St. Elizabeth Healthcare, and how I think AI may help improve patient care and provider QOL (Quality of Life).
Our session:
Digital Innovation: Cancer-Specific AI Use Cases
Friday, September 06, 2024
9:50 AM – 10:50 AM
The session will focus on the real-world application of digital innovations aimed at enhancing performance and care delivery within the healthcare sector. Our panel will explore the realm of digital innovation in cancer care, offering insights from both community practice and hospital perspectives.
Additionally, the session will discuss the intricate intersection of artificial intelligence (AI) and patient care, providing strategies for effectively navigating this evolving landscape.
Information of registration below. Hope to see you there.”
Quoting post by Clinical Pathways Congress + Cancer Care Business Exchange:
“Global Digital Health Market to Skyrocket at 15.1% CAGR!
The global digital health market, valued at $122.66 billion in 2020, is projected to expand at an impressive compound annual growth rate (CAGR) of 15.1% from 2021 to 2028. This rapid growth highlights the increasing adoption and necessity of digital health technologies in modern healthcare.
Why You Need to Attend:
Digital innovations are not just trends—they are essential for revolutionizing patient care, improving outcomes, and saving lives. Embracing these advancements fulfills our ethical duty to provide top-tier care while ensuring sustainability and scalability in a rapidly evolving healthcare environment.
What You’ll Learn:
- How end-users from community practices to hospitals leverage cutting-edge digital tools to enhance performance and elevate care standards.
- Tactical ideas for navigating the AI frontier in healthcare.
- Strategies to keep patient-focused outcomes at the forefront of technological advancements.
Join our expert panel to explore the intersection of technology and compassion in healthcare, and be part of shaping the future of care delivery.
Date: September 6-8, 2024
Location: Westin Copley Place, Boston, MA
Don’t miss this opportunity to gain crucial insights and actionable strategies for integrating digital innovations into your practice. Together, we can ensure better care delivery for all.”
Source: Douglas Flora/LinkedIn and Clinical Pathways Congress + Cancer Care Business Exchange/LinkedIn
Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.
As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.